The exon 3-deleted/full-length growth hormone receptor polymorphism and response to growth hormone therapy in growth hormone deficiency and Turner syndrome: a multicenter study.

Firdevs Bas,Feyza Darendeliler,Zehra Aycan,Ergun Çetinkaya,Merih Berberoğlu,Zeynep Şıklar,Gönül Öcal,Özlem Timirci,Semra Çetinkaya,Şükran Darcan,Damla Gökşen Şimşek,Aysun Bideci,Peyami Cinaz,Ece Böber,Korcan Demir,Abdullah Bereket,Serap Turan,M. Emre Atabek,Filiz Tutunculer,Turgay Isbir,Nilüfer Bozkurt,Sema Kabataş Eryılmaz,Ozan Uzunhan,Banu Kucukemre Aydin,Rüveyde Bundak

The exon 3-deleted/full-length growth hormone receptor polymorphism and response to growth hormone therapy in growth hormone deficiency and Turner syndrome: a multicenter study.

2012

Background/Aim: The exon 3-deleted/full-length (d3/fl) growth hormone (GH) receptor (GHR) polymorphism has been associated with responsiveness to GH therapy in some diagnostic group

Keywords:

Hormone
Hormone therapy
Hormone receptor
Growth hormone receptor
Internal medicine
Endocrinology
Turner syndrome
Growth hormone deficiency
Thyroid hormone receptor beta
Receptor
Medicine
Polymorphism (computer science)
Exon

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations